CliffBio
small molecule

BIPHETAMINE 20

AMPHETAMINE RESIN COMPLEX; DEXTROAMPHETAMINE RESIN COMPLEX

Loss of exclusivity—loss of exclusivity
CompanyUCB →See this company's full patent-cliff portfolio

Drug detail

Brand nameBIPHETAMINE 20
Active ingredientAMPHETAMINE RESIN COMPLEX; DEXTROAMPHETAMINE RESIN COMPLEX
StrengthEQ 10MG BASE;EQ 10MG BASE
Dosage formCAPSULE, EXTENDED RELEASE
RouteORAL
ModalitySmall molecule
Marketing statusDISCN

More from UCB

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

BIPHETAMINE 20 patent cliff — loss of exclusivity — | CliffBio